Education
About Us
Working with TipRanks
Follow Us
AegirBio AB (DE:52Q)
FRANKFURT:52Q
52Q Stock Chart & Stats
Day’s Range― - ―
52-Week Range<€0.01 - €0.02
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€5.57M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)2.85M
Price to Earnings (P/E)―
Beta8.97
Next Earnings
May 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding1,185,835,800
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
52Q FAQ
What was AegirBio AB’s price range in the past 12 months?
AegirBio AB lowest stock price was <€0.01 and its highest was €0.02 in the past 12 months.
What is AegirBio AB’s market cap?
AegirBio AB’s market cap is €5.57M.
When is AegirBio AB’s upcoming earnings report date?
AegirBio AB’s upcoming earnings report date is May 21, 2025 which is 11 days ago.
How were AegirBio AB’s earnings last quarter?
AegirBio AB released its earnings results on Aug 24, 2021. The company reported -€0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.008.
Is AegirBio AB overvalued?
According to Wall Street analysts AegirBio AB’s price is currently Overvalued.
Does AegirBio AB pay dividends?
AegirBio AB does not currently pay dividends.
What is AegirBio AB’s EPS estimate?
AegirBio AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AegirBio AB have?
AegirBio AB has 1,185,835,800 shares outstanding.
What happened to AegirBio AB’s price movement after its last earnings report?
AegirBio AB reported an EPS of -€0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of AegirBio AB?
Currently, no hedge funds are holding shares in DE:52Q
Company Description
AegirBio AB
AegirBio AB is a Swedish diagnostic company that offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company's products include Monator - drug monitoring of tysabri in MS, Veritope, and Magniareader.
Technical Analysis
Clinical Laserthermia Systems AB Class B
―
S2Medical AB Class B
―
Qlife Holding AB
―
SpectraCure AB
―
Acarix AB
―